HCW Biologics Inc.
NASDAQ:HCWB
6.9 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 2.567 | 2.842 | 6.722 | 0 | 4.1 | 0 |
| Cost of Revenue
| 1.607 | 2.281 | 4.136 | 0.544 | 0 | 0.422 |
| Gross Profit
| 0.959 | 0.56 | 2.586 | -0.544 | 4.1 | -0.422 |
| Gross Profit Ratio
| 0.374 | 0.197 | 0.385 | 0 | 1 | 0 |
| Reseach & Development Expenses
| 6.389 | 7.676 | 9.338 | 8.174 | 7.255 | 5.391 |
| General & Administrative Expenses
| 6.84 | 13.084 | 8.327 | 4.976 | 2.436 | 1.803 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.84 | 13.084 | 8.327 | 4.976 | 2.436 | 1.803 |
| Other Expenses
| 15.603 | 5.517 | 0.305 | 0.218 | 0.233 | 0.171 |
| Operating Expenses
| 28.832 | 26.278 | 17.665 | 13.368 | 9.924 | 7.365 |
| Operating Income
| -29.48 | -25.717 | -15.079 | -13.368 | -5.825 | -7.365 |
| Operating Income Ratio
| -11.485 | -9.05 | -2.243 | 0 | -1.421 | 0 |
| Total Other Income Expenses Net
| -0.544 | 0.723 | 0.178 | 0.505 | 0.022 | 0.072 |
| Income Before Tax
| -30.024 | -24.994 | -14.901 | -12.862 | -5.802 | -7.293 |
| Income Before Tax Ratio
| -11.697 | -8.795 | -2.217 | 0 | -1.415 | 0 |
| Income Tax Expense
| 0 | 0 | -0.178 | -0.505 | -0.022 | -0.072 |
| Net Income
| -30.024 | -24.994 | -14.723 | -12.357 | -5.78 | -7.221 |
| Net Income Ratio
| -11.697 | -8.795 | -2.19 | 0 | -1.41 | 0 |
| EPS
| -0.77 | -0.7 | -0.41 | -0.35 | -0.16 | -0.2 |
| EPS Diluted
| -0.77 | -0.7 | -0.41 | -0.35 | -0.16 | -0.2 |
| EBITDA
| -27.681 | -23.576 | -14.184 | -12.824 | -5.252 | -6.943 |
| EBITDA Ratio
| -10.784 | -8.296 | -2.11 | 0 | -1.281 | 0 |